Research and Training in Complementary and Integrative Health

Active

Assistance listing
93.213
Agency
Grant awards
3,796 $2,993,837,270 in federal obligations

Program facts

Also known as
National Center for Complementary and Integrative Health
Assistance types
  • Project Grant
  • Cooperative Agreement
  • Block Grant
Treasury account
  • 75-0896-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The National Center for Complementary and Integrative Health (NCCIH) within the National Institutes of Health funds research and training in complementary and integrative health approaches, with CFDA 93.213, and most recently awarded funding on February 28, 2027. The program supports scientific investigation into the fundamental science, safety, and usefulness of complementary and integrative treatments and practices, favoring rigorous mechanistic understanding alongside clinical application.

Awarded grants target diverse conditions through mind-body and bioactive interventions: dietary modulation of the gut microbiota during pregnancy and infant health, role strain and self-compassion in ALS caregivers, prenatal mindfulness for stress and birth outcomes, family resilience in breast cancer survivors, bidirectional brain-computer interfaces combining EEG and ultrasound neuromodulation, pain catastrophizing neurobiology in burn survivors, mobile app-based mindfulness for spinal cord injury pain, singing for cardiovascular health in older adults, and multimodal interventions for chronic pain in diverse populations. Recent awards also span microbiome therapeutics, natural product drug discovery for analgesia, cannabis coaching for chronic low back pain, acupuncture in emergency departments, and music-based interventions for dementia and chronic pain.

The program is predominantly Project Grants (91 percent of 3,465 awards), with smaller shares of Block Grants (6 percent) and Cooperative Agreements (3 percent). The National Center for Complementary and Integrative Health leads funding with $1.79 billion across 942 awards, followed by the broader NIH with $959.7 million across 2,733 awards. Combined federal dollars obligated total $2.99 billion across 3,796 awards since 1992. Annual award volume averaged 61–83 grants per year from 2023–2026, dropping to 3 awards in early 2027. Recent project awards range from $46 thousand to $1.67 million, with several multi-year efficacy trials, feasibility studies, and proof-of-concept investigations in the $600 thousand to $800 thousand range.

Grant opportunities currently open include HEAL Initiative funding for translating addiction and chronic pain research into practice (RFA-DA-27-016, due Feb 9, 2029), NIH pragmatic trials in health care systems (PAR-28-010), small business transition grants for new entrepreneurs (PAR-27-039 and PAR-27-040), and mind and body interventions for whole person health via emotional well-being mechanisms (PAR-25-449, due Jun 7, 2028). Applicants include universities, research institutions, nonprofits, and small businesses; foreign organizations are ineligible for most NCCIH mechanisms.

Objective and description

Objective

NCCIH is the lead Federal agency for scientific research on the fundamental science, usefulness, and safety of complementary and integrative treatments and practices. NCCIH seeks to build knowledge across disciplines, focusing on the whole person, an

Description

The National Center for Complementary and Integrative Health (NCCIH) provides funding for research into complementary and integrative health approaches. Eligible entities (including, but not limited to: research and academic institutions, private companies) may submit research grant applications using the Grants.gov website. All applications undergo a rigorous, 2-stage, peer-review system, and funding decisions are made based on the review of applications that are most meritorious and responsive to the mission of NCCIH.

Eligibility

Applicant eligibility

Universities, colleges, hospitals, laboratories, and other public or private nonprofit domestic institutions, including State and local units of government, and individuals are eligible to make application for grant support of research by a named principal investigator or a research career development candidate. For-profit organizations are also eligible, with the exception of NRSA. Individual NRSA awardees must be nominated and sponsored by a public or nonprofit private institution having staff and facilities appropriate to the proposed research training program. All NRSA awardees must be citizens or have been admitted to the United States for permanent residence. To be eligible, predoctoral candidates must have completed the baccalaureate degree, and postdoctoral awardees must have a professional or scientific degree (e.g., M.D., Ph.D., D.D.S., D.O., N.D., D.C., D.V.M., Sc.D., D.Eng., or equivalent domestic or foreign degree). SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is being proposed and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. or its possessions. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which researches proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.

Beneficiary eligibility

Any nonprofit or for-profit organization, company, or institution engaged in biomedical research.

Uses of assistance

Research Grants provide funds for salaries, equipment, supplies, travel, and other expenses associated with scientific investigation relevant to program objectives. Individual National Research Service Awards (NRSAs) are made to individuals for research training in specified biomedical shortage areas. In addition, grants may be made to institutions to enable them to make NRSAs to individuals selected by them. Each individual who receives a NRSA is obligated upon termination of the award to comply with certain service and payback provisions. Small Business Innovation Research (SBIR) Phase I grants (of approximately 6-months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants are for the continuation of the research initiated in Phase I that are likely to result in commercial products or processes. Only Phase I awardees are eligible to receive Phase II support. Small Business Technology Transfer (STTR) Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential on Phase II application.

Length and time phasing of assistance

Research Project Grants (including most Cooperative Agreements): Awards are usually made for a 12-month period with recommendation of up to 4 years of additional support. SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years. See the following for information on how assistance is awarded/released: The Notice of Award (NoA) is the legal document issued to notify the grantee that an award has been made and that funds may be requested from the designated HHS payment system or office. A NoA is issued for the initial budget period. If subsequent budget periods are also approved, the NoA will include a reference to those budgetary commitments. Funding for subsequent budget periods are generally provided in annual increments following the annual assessment of progress. This funding is also contingent on the availability of funds. The NoA includes all applicable terms of award either by reference or specific statements. It provides contact information for the assigned program officer and grants management specialist. The grantee accepts an NIH award and its associated terms and conditions by drawing or requesting funds from the Payment Management System, or upon the endorsement of a check from the US Treasury for foreign awardees.

How to apply

Criteria for selecting proposals

The major elements in evaluating proposals include assessments of: (1) the scientific merit innovation and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; (6) the relevance and importance to the announced program objectives and when applicable,and (7) the adequacy of assurances detailing the proposed means for safeguarding human or animal subjects. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; and (8) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.

Award procedure

Award Procedure: All accepted applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score ranging from the best (10) to worst (90) compete for available funds based on scientific merit, program relevance, and program balance and are made annually. Initial award provides funds for the first budget period (usually 12 months) and Notice of Grant Award (Form PHS 1533) indicates support recommended for remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.

Time to approval or disapproval

Overall from 180 to 300 days. Research Grants and Cooperative Agreements: approximately 6-10 months; National Service Research Awards: 6-9 months; SBIR/STTR awards 6 - 7 months.

Renewals

Research grants: renewals by competitive application and review. Extension by request and administrative action. National Research Service Awards: individual awards may be made for 1, 2, or 3 years. No individual may receive NIH fellowship support at the postdoctoral level for more than 3 years.

Appeals

An applicant institution (including the Authorized Organization Representative and the Program Director/Principal Investigator (PD/PI)) may question the substantive or procedural aspects of the review of their application by submitting an appeal. An appeal is a written communication from the applicant that meets the following three criteria: 1) is received after issuance of the summary statement and up to 30 calendar days after the second level of peer review, 2) describes a flaw or perceived flaw in the review process for a particular application, 3) is based on one or more of four allowable issues (described below). The four allowable issues are: (1) evidence of bias on the part of one or more peer reviewers; (2) conflict of interest, as specified in regulation at 42 CFR 52h.5."Scientific Peer Review of Research Grant Applications and Research and Development Contract Projects", on the part of one or more peer reviewers; (3) lack of appropriate expertise within the scientific review group (which performed the peer review); and (4) factual error(s) made by one or more reviewers that could have substantially altered the outcome of review. A description of the NIH Peer Review Policy and Procedures is available at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Grant opportunities

Opportunity Status Posted Applications due
HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) RFA-DA-27-016 Open
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) PAR-27-040 Forecasted —
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) PAR-27-039 Forecasted —
NIH Pragmatic Trials Conducted in Health Care Systems PAR-28-010 Forecasted —
Feasibility Studies to Inform the Design of Future Clinical Trials PAR-28-011 Forecasted —
Establishing a Research Network to Guide Foundational Research on Human Consciousness RFA-AT-27-002 Forecasted —
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) PAR-27-045 Open
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) PAR-27-076 Open
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 Open
Interdisciplinary Research Networks to Advance Biomedical Research on Resilience and Health Optimization RFA-AT-26-001 Past —
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) RFA-NS-27-002 Open
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) RFA-NS-28-010 Open
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 Open
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) RFA-DA-28-012 Open
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science 25-542 Closed
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) RFA-DA-28-011 Open
Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required) PAR-28-091 Open
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 Open
Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) PA-27-037 Open
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) RFA-DC-27-004 Open
Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required) PAR-25-449 Open
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) PAR-27-077 Open
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-27-007 Open
Small Business Translator: MedTech and Digital Health Technologies FOR-NS-25-017 Past —
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) RFA-DA-27-004 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-425 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) PA-25-422 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) PA-25-423 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-426 Open
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) PAR-25-383 Open
NIH Blueprint for Neuroscience: Coordination Center for Interoception Research (BPCCIR) (U24, Clinical Trial Not Allowed) RFA-AT-25-004 Closed
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) RFA-OD-25-003 Open
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) PAR-25-378 Open
Limited Competition: Advancing the Science of Complementary and Integrative Health Approaches to Improve Maternal Health Outcomes (R01 Clinical Trial Required) RFA-AT-25-002 Closed
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) RFA-AT-25-003 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) PA-25-280 Open
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) PA-25-304 Open
NIH Research Project Grant (Parent R01 Clinical Trial Required) PA-25-305 Open
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-25-301 Open
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) PA-25-303 Closed
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) PA-25-306 Open
NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required) PA-25-307 Closed
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) RFA-DA-25-077 Closed
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) RFA-DA-25-078 Closed
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) RFA-AA-24-012 Closed
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) PAR-25-154 Closed
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) RFA-EY-25-001 Closed
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-25-298 Open
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Grant awards

Award Recipient Federal obligations Awarded
Investigating dietary modulation of the GUT microbiota during pregnancy and its impact on infant microbiota assembly… F32AT013979 The Leland Stanford Junior University $76,300
Role strain, self-compassion, and wellbeing in ALS caregiving: a mediation analysis F31AT013994 The Washington University $53,114
Trajectories of maternal stress and mindfulness in pregnancy: consequences for maternal health and birth outcomes F31AT013548 Colorado State University $46,034
Addressing unmet care needs in breast cancer survivors and caregivers: the role of family resilience F31AT013682 Michigan State University $90,976
Group singing or solo singing to improve vascular health in older adults with coronary artery disease (got voice): a… R34AT013239 The Medical College Of Wisconsin, Inc. $648,000
Sensory systems: interoception and exteroception R13AT013978 Keystone Symposia On Molecular And Cellular Biology $20,200
Neurobiology of pain catastrophizing in burn survivors: identification and targeting of a critical treatment mechanism R01AT013875 The Spaulding Rehabilitation Hospital Corporation $732,927
Bidirectional brain-computer interface with closed-loop mind-body interactions R01AT013779 Carnegie-Mellon University $616,764
Effects of a mobile APP-based mindfulness intervention in persons with spinal cord injury and chronic pain: a… R01AT013248 Mayo Clinic Jacksonville (A Nonprofit Corporation) $780,208
Multicenter feasibility of integrative health coaching for back pain after an emergency department discharge R01AT013474 Vanderbilt University Medical Center $624,778

Latest 10 of 3,796 listed here. See the rest on GovTribe.

Top recipients by federal obligations

Rank Recipient Federal obligations Share
1 The General Hospital Corporation $125,864,069 4%
2 The Regents Of The University Of California. San Francisco $74,704,447 2%
3 Duke University $72,119,793 2%
4 Regents Of The University Of Minnesota $60,346,431 2%
5 University Of California, San Diego $51,372,554 2%
6 University Of California, LOS Angeles $50,705,171 2%
7 University Of Washington $49,890,301 2%
8 Yale Univ $48,514,856 2%
9 University Of Illinois $43,423,156 1%
10 The Leland Stanford Junior University $39,812,962 1%

10 of 468 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $82,325,112
FY2025 $164,911,797
FY2024 $222,592,037
FY2023 $261,642,711
FY2022 $232,962,377
FY2021 $247,889,527
FY2020 $148,733,639
FY2019 $149,394,195
FY2018 $126,574,085
FY2017 $108,087,945
FY2016 $110,826,456
FY2015 $100,048,562
FY2014 $103,093,815
FY2013 $99,028,295
FY2012 $109,414,344
FY2011 $99,199,901
FY2010 $98,869,742
FY2009 $101,833,630
FY2008 $47,761,293
FY2007 $70,335,922
FY2006 $92,014,286
FY2005 $92,546,548
FY2004 $88,855,215
FY2003 $89,383,965
FY2002 $79,565,238
FY2001 $34,758,507
Show all 26

Quick answers

What is Assistance Listing 93.213?

Assistance Listing 93.213 is Research and Training in Complementary and Integrative Health, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Research and Training in Complementary and Integrative Health?

Its CFDA number is 93.213: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.213 awarded?

3,796 grant awards under 93.213 have obligated $2,993,837,270 in federal funds to 468 recipients.

Who receives the most funding from 93.213?

The recipients obligated the most under Research and Training in Complementary and Integrative Health are The General Hospital Corporation ($125,864,069), The Regents Of The University Of California. San Francisco ($74,704,447) and Duke University ($72,119,793).

How much did 93.213 obligate in fiscal year 2025?

Grants under 93.213 obligated $164,911,797 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.213?

38 of the latest 50 opportunities under 93.213 are open or forecasted. The latest, HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional), was posted on June 4, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program